Kenvue Inc. (KVUE)
NYSE · USD · Consumer Defensive · Household & Personal Products
$19.50 (-0.36%) as of
Key statistics
- Market cap
- 37.46B
- P/E (TTM)
- 22.67
- Forward P/E
- 15.73
- EPS (TTM)
- 0.86
- Dividend yield
- 4.31%
- 52-week range
- 14.02 – 20.13
- Beta
- 0.45
- Revenue (TTM)
- 15.41B
- Profit margin
- 10.76%
- Analyst target
- $19.50
- Volume
- 9.49M
About Kenvue Inc.
Kenvue Inc. operates as a consumer health company in the United States, rest of North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates in three segments: Self Care, Skin Health and Beauty, and Essential Health. The company offers over-the-counter medicine for cough, cold and allergy, pain care, digestive health, smoking cessation, and eye care, as well as other naturally inspired and self-care products, digital diagnostics, and telemedicine; face and body care, hair, sun, and other care products; oral and baby care, women's health, wound care, and other essential health products; tampons; cosmetics; and vitamins and supplements. It sells its products under the Benadryl, Calpol, Motrin, Nicorette, Rhinocort, Tylenol, Zarbee's Naturals, and Zyrtec; Aveeno, Dr.Ci:Labo, Le Petit Marseillais, Lubriderm, Neutrogena, OGX, and Rogaine; BAND-AID, Carefree, Desitin, Johnson's, Listerine, o.b., and Stayfree; and ORSL, Clean & Clear, Versalie, Benylin, Daktarin, Imodium, Johnson's Baby, Johnson's Adult, Maui Moisture, Microlax, Motilium, Neosporin, Neostrata, Pepcid, Pulmicort, Regaine, Sudafed, and Visine/Vispring/Visclear brands. Kenvue Inc. was incorporated in 2022 and is headquartered in Summit, New Jersey.
- Sector
- Consumer Defensive
- Industry
- Household & Personal Products
- Headquarters
- Summit, NJ, United States
- Employees
- 21,780
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.